Emotion processing, major depression, and functional genetic variation of neuropeptide Y

Archives of General Psychiatry

Volumn 68, Issue 2, 2011, Pages 158-166

  Mickey, Brian J ^a,b   Zhou, Zhifeng ^c   Heitzeg, Mary M ^a,b   Heinz, Elizabeth ^c   Hodgkinson, Colin A ^c   Hsu, David T ^a,b   Langenecker, Scott A ^a,b   Love, Tiffany M ^a   Peciña, Marta ^a   Shafir, Tal ^a,b   Stohler, Christian S ^d   Goldman, David ^c   Zubieta, Jon Kar ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE Y;

ADULT; AGE; ANTERIOR CINGULATE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EMOTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NUCLEOTIDE SEQUENCE; PAIN; PROTEIN EXPRESSION; SEX; STRESS; VENTROMEDIAL PREFRONTAL CORTEX;

ADULT; AMYGDALA; AROUSAL; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; EMOTIONS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GYRUS CINGULI; HAPLOTYPES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE NET; NEUROPEPTIDE Y; PAIN; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; REFERENCE VALUES; YOUNG ADULT;

EID: 79951476373     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.197     Document Type: Article

References (50)

1. Dalgleish T. The emotional brain. Nat Rev Neurosci. 2004;5(7):583-589.
2. Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage. 2002;16(2):331-348. (Pubitemid 34852450)
3. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception, I: the neural basis of normal emotion perception. Biol Psychiatry. 2003;54(5):504-514. (Pubitemid 37289437)
4. Bouchard TJ Jr, McGue M. Genetic and environmental influences on human psychological differences. J Neurobiol. 2003;54(1):4-45. (Pubitemid 36050067)
5. Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossor MN, Roberts GW, Crow TJ, Tatemoto K, Polak JM. Neuropeptide Y distribution in human brain. Nature. 1983;306(5943):584-586. (Pubitemid 14203823)
6. Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM. Neuropeptide Y distribution in the rat brain. Science. 1983;221(4613):877-879.
7. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y: a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 1982;296(5858):659-660. (Pubitemid 12089070)
8. Gehlert DR. Introduction to the reviews on neuropeptide Y. Neuropeptides. 2004;38(4):135-140. (Pubitemid 39158854)
9. Kask A, Harro J, von Hörsten S, Redrobe JP, Dumont Y, Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev. 2002;26(3):259-283. (Pubitemid 34555409)
10. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides. 2004;38(4):213-224. (Pubitemid 39158860)
11. Smith PA, Moran TD, Abdulla F, Tumber KK, Taylor BK. Spinal mechanisms of NPY analgesia. Peptides. 2007;28(2):464-474. (Pubitemid 46176270)
12. Brumovsky P, Shi TS, Landry M, Villar MJ, Hökfelt T. Neuropeptide tyrosine and pain. Trends Pharmacol Sci. 2007;28(2):93-102. (Pubitemid 46161835)
13. Craig AD. A new view of pain as a homeostatic emotion. Trends Neurosci. 2003;26(6):303-307. (Pubitemid 36700414)
14. Morgan CA III, Rasmusson AM, Wang S, Hoyt G, Hauger RL, Hazlett G. Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol Psychiatry. 2002;52(2):136-142. (Pubitemid 34759984)
15. Morgan CA III, Rasmusson AM, Winters B, Hauger RL, Morgan J, Hazlett G, Southwick S. Trauma exposure rather than posttraumatic stress disorder is associated with reduced baseline plasma neuropeptide-Y levels. Biol Psychiatry. 2003;54(10):1087-1091. (Pubitemid 37415043)
16. Morgan CA III, Wang S, Southwick SM, Rasmusson A, Hazlett G, Hauger RL, Charney DS. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry. 2000;47(10):902-909. (Pubitemid 30243178)
17. Yehuda R, Brand S, Yang RK. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry. 2006;59(7):660-663. (Pubitemid 43357961)
18. Berrettini WH, Doran AR, Kelsoe J, Roy A, Pickar D. Cerebrospinal fluid neuropeptide Y in depression and schizophrenia. Neuropsychopharmacology. 1987;1(1):81-83. (Pubitemid 19125252)
19. Caberlotto L, Hurd YL. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport. 1999;10(8):1747-1750. (Pubitemid 29354304)
20. Czermak C, Hauger R, Drevets WC, Luckenbaugh DA, Geraci M, Charney DS, Neumeister A. Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression. J Affect Disord. 2008;110(3):277-281.
21. Hashimoto H, Onishi H, Koide S, Kai T, Yamagami S. Plasma neuropeptide Y in patients with major depressive disorder. Neurosci Lett. 1996;216(1):57-60. (Pubitemid 26321049)
22. Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, Sjögren M, Asberg M, Ekman R, Wahlestedt C, Agren H. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res. 2004;38(2):113-121. (Pubitemid 38134451)
23. Ordway GA, Stockmeier CA, Meltzer HY, Overholser JC, Jaconetta S, Widdowson PS. Neuropeptide Y in frontal cortex is not altered in major depression. J Neurochem. 1995;65(4):1646-1650.
24. Widdowson PS, Ordway GA, Halaris AE. Reduced neuropeptide Y concentrations in suicide brain. J Neurochem. 1992;59(1):73-80.
25. Widerlöv E, Lindström LH, Wahlestedt C, Ekman R. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res. 1988;22(1):69-79.
26. Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, Virkkunen M, Mash DC, Lipsky RH, Hu XZ, Hodgkinson CA, Xu K, Buzas B, Yuan Q, Shen PH, Ferrell RE, Manuck SB, Brown SM, Hauger RL, Stohler CS, Zubieta JK, Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature. 2008;452(7190):997-1001. (Pubitemid 351589618)
27. Heitzeg MM, Nigg JT, Yau WY, Zubieta JK, Zucker RA. Affective circuitry and risk for alcoholism in late adolescence: differences in frontostriatal responses between vulnerable and resilient children of alcoholic parents. Alcohol Clin Exp Res. 2008;32(3):414-426. (Pubitemid 351301004)
28. Bradley MM, Lang PJ. Affective Norms for English Words (ANEW): Instruction Manual and Affective Ratings. Gainesville: Center for Research in Psychophysiology, University of Florida; 1999.
29. Ward BD. AlphaSim. http://afni.nimh.nih.gov. Accessed January, 2010.
30. Domschke K, Dannlowski U, Hohoff C, Ohrmann P, Bauer J, Kugel H, Zwanzger P, Heindel W, Deckert J, Arolt V, Suslow T, Baune BT. Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol. 2010;20(5):301-309.
31. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception, II: implications for major psychiatric disorders. Biol Psychiatry. 2003;54(5):515-528. (Pubitemid 37289438)
32. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology. 2010;35(1):192-216.
33. Yoshimura S, Okamoto Y, Onoda K, Matsunaga M, Ueda K, Suzuki S, Shigetoyamawaki. Rostral anterior cingulate cortex activity mediates the relationship between the depressive symptoms and the medial prefrontal cortex activity. J Affect Disord. 2010;122(1-2):76-85.
34. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ. The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry. 2002;59(7):597-604. (Pubitemid 34747239)
35. Hsu DT, Langenecker SA, Kennedy SE, Zubieta JK, Heitzeg MM. fMRI BOLD responses to negative stimuli in the prefrontal cortex are dependent on levels of recent negative life stress in major depressive disorder. Psychiatry Res. 2010;183(3):202-208.
36. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293(5528):311-315. (Pubitemid 32694749)
37. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. Mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci. 2002;22(12):5100-5107. (Pubitemid 37465623)
38. Watson D, Clark LA. The PANAS-X: Manual for the Positive and Negative Affect Schedule - Expanded Form. Iowa City: University of Iowa; 1994.
39. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063-1070.
40. Kennedy SE, Koeppe RA, Young EA, Zubieta JK. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry. 2006;63(11):1199-1208. (Pubitemid 44708077)
41. Mickey BJ, Ducci F, Hodgkinson CA, Langenecker SA, Goldman D, Zubieta JK. Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo. J Neurosci. 2008;28(44):11354-11359.
42. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. New York: Biometric Research Dept, New York Psychiatric Institute; 1995.
43. Burmeister M, McInnis MG, Zöllner S. Psychiatric genetics: progress amid controversy. Nat Rev Genet. 2008;9(7):527-540. (Pubitemid 351972757)
44. Sullivan PF. Spurious genetic associations. Biol Psychiatry. 2007;61(10):1121-1126. (Pubitemid 46669468)
45. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ. Selective attention to emotional stimuli in a verbal go/no-go task: an fMRI study. Neuroreport. 2000;11(8):1739-1744. (Pubitemid 30350344)
46. Epstein J, Pan H, Kocsis JH, Yang Y, Butler T, Chusid J, Hochberg H, Murrough J, Strohmayer E, Stern E, Silbersweig DA. Lack of ventral striatal response to positive stimuli in depressed vs normal subjects. Am J Psychiatry. 2006;163(10):1784-1790. (Pubitemid 44522488)
47. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008;213(1-2):93-118.
48. Sajdyk TJ, Shekhar A, Gehlert DR. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides. 2004;38(4):225-234. (Pubitemid 39158861)
49. Charney DS. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry. 2004;161(2):195-216. (Pubitemid 38419269)
50. Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci. 2009;10(6):446-457.